English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 8, 2026

GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Biohaven outlines new strategy after setbacks and prepares muscle-sparing drug study
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

CDMOs look to FDA's PreCheck program for support at new US production sites
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Penn Medicine earns national recognition for top clinical research achievements
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

ACAAI offers guidance for an allergy-safe Valentine’s Day
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

HonorHealth Research Institute administers new investigational stroke drug as part of national trial
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Study links long-term air pollution exposure with higher ALS risk
+ Pharmaceuticals
Patient Daily | Feb 8, 2026

Global Virus Network urges action amid rising measles cases worldwide

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes